MENU
業績

トップページ ＞ 業 績 ＞ 論文発表 2025年

2025年 論文発表

＜英文＞ 29論文

  1. Yoshimura R, Shimizu N, Togo M, Yamamoto S, Nao T, Shimamoto T, Fukuhara H, Fukata S, Ashida S, Karashima T, Saito M, Inoue K.
    Cough-associated detrusor overactivity resolved after intravesical onabotulinumtoxin A injection: A case report.
    Urol Case Rep. 2025 Jul 18; 62:103129. doi: 10.1016/j.eucr.2025.103129.
  2. Yoshimura R, Shimizu N, Togo M, Kurano Y, Nao T, Fukuhara H, Fukata S, Karashima T, Saito M, Inoue K.
    Persistent bladder dysfunction after martius flap repair for a radiation-induced vesicovaginal fistula: A case report.
    Continence Reports. 2025 Dec doi:10.1016/j.contre.2025.100104.
  3. Shigehisa R, Ashida S, Atagi K, Yamamoto S, Fukuhara H, Fukata S, Iwashita W, Kurabayashi A, Inoue K.
    Primary adenosquamous carcinoma of the prostate with rapid elevation of prostate-specific antigen: a case report.
    J Med Case Rep. 2025 Oct 21;19(1):525. doi: 10.1186/s13256-025-05606-3.
  4. Shimizu N, Shimizu T, Togo M, Higashi Y, Fukata S, Inoue K, Saito M.
    Potential role of brain nitric oxide in inhibiting α7 nicotinic acetylcholine receptor-mediated suppression of the micturition reflex in rats. Nitric Oxide. 2025 Oct; 158:116-123. doi: 10.1016/j.niox.2025.07.003. Epub 2025 Jul 26.
  5. Yamashita E, Ashida S, Yoshimura R, Iga R, Kurano Y, Yamamoto S, Shimamoto T, Fukuhara H, Fukata S, Kurabayashi A, Karashima T, Inoue K.
    Successful treatment of large-cell neuroendocrine carcinoma of the prostate with pembrolizumab: a case report.
    J Med Case Rep. 2025 Nov 18;19(1):589. doi: 10.1186/s13256-025-05670-9.
  6. Fukata S, Shimasaki S, Yamashita E, Kurano Y, Shigehisa R, Atagi K, Takemori D, Yamamoto S, Osakabe H, Nao T, Shimamoto T, Fukuhara H, Shimizu N, Ashida S, Karashima T, Inoue K.
    Efficacy of preventive techniques against postoperative inguinal hernia in patients who underwent robot-assisted radical prostatectomy for Japanese patients.
    J Robot Surg. 2025 Nov 1;19(1):730. doi: 10.1007/s11701-025-02927-9.
  7. Takemori D, Shigehisa R, Shimasaki S, Yamashita E, Kurano Y, Atagi K, Ota Y, Yamamoto S, Osakabe H, Nao T, Shimamoto T, Fukuhara H, Shimizu N, Fukata S, Ashida S, Inoue K.
    Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case Report.
    IJU Case Rep. 2025 Jul 16;8(5):470-474. doi: 10.1002/iju5.70069. eCollection 2025 Sep.
  8. Yamamoto S, Fukata S, Karashima T, Kurabayashi A, Yoshimura R, Furihata K, Shiba Y, Nao T, Satake H, Inoue K.
    Robust response to pembrolizumab plus lenvatinib in a patient with renal cell carcinoma with rhabdoid features: A case report.
    Urol Case Rep. 2025 Jul 23;62:103140. doi: 10.1016/j.eucr.2025.103140. eCollection 2025 Sep.
  9. Yamamoto S, Fukuhara H, Shigehisa R, Hara T, Shibanaka Y, Inoue K.
    Clinical utility of photodynamic diagnosis with 5-aminolevulinic acid hydrochloride for detecting carcinoma in situ independent of urine cytology classification.
    Photodiagnosis Photodyn Ther. 2025 Aug;54:104722. doi: 10.1016/j.pdpdt.2025.104722. Epub 2025.
  10. Fukuhara H, Shigehisa R, Saito K, Hara T, Otsuka N, Katsumata Y, Kawano T, Inoue K.
    　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　　Risk factors of severe prolonged hypotension induced by 5-aminolevulinic acid during photodynamic diagnosis-assisted transurethral resection of bladder tumor.
    Photodiagnosis Photodyn Ther. 2025 Aug;54:104667. doi: 10.1016/j.pdpdt.2025.104667. Epub 2025.
  11. Yamamoto S, Fukuhara H, Kuroiwa H, Shigehisa R, Osakabe H, Nao T, Shimamoto T, Shimizu N, Fukata S, Ashida S, Karashima T, Inoue K.
    Preoperative Pyuria as a Predictor of False-Positive Rates in the Photodynamic Diagnosis of Nonmuscle-Invasive Bladder Cancer Using Oral 5-Aminolevulinic Acid.
    Int J Urol. 2025 Oct;32(10):1361-1368. doi: 10.1111/iju.70134. Epub 2025.
  12. Karashima T, Komatsu T, Yamamoto S, Atagi K, Hashida H, Fukuhara H, Tamura K, Ashida S, Shuin T, Udaka K, Shimizu T, Saito M, Shimizu N, Inoue K: Transcutaneous Imiquimod Combined With Anti-Programmed Cell Death-1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma.
    Cancer Med. 2025 May;14(10):e70966. doi: 10.1002/cam4.70966.
  13. Fukuhara H, Nishimura T, Shimojo Y, Inoue K.
    Comparison of fluorescence intensity of protoporphyrin IX as observed on the screen of different cystoscopic systems.
    Photodiagnosis Photodyn Ther. 2025 Feb;51:104425. doi: 10.1016/j.pdpdt.2024.104425. Epub 2024 Nov 28.
  14. Kanemoto S, Yamamoto S, Hino K, Tsuboi K, Kakizaki M, Nishiyama Y, Fukata S, Arata R, Inoue K, Ono N.
    Multiple Bone Metastases From Non-Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report
    IJU Case Reports, 2026; 9:e70119, https://doi.org/10.1002/iju5.70119
  15. Togo M, Shimizu T, Furihata K, Hamada C, Higashi Y, Fukata S, Shimizu N, Kurabayashi A, Saito M. Establishment of a Male Rat Model Exhibiting Myogenic Underactive Bladder‐Like Features Following Bladder Cryoinjury. Int J Urol. 2025 Oct 7. doi: 10.1111/iju.70252.
  16. Shimizu T, Shimizu N, Tsubouchi S, Togo M, Higashi Y, Saito M.
    Centrally administered prostaglandin E2 suppresses the micturition reflex in rats. J Pharmacol Sci. 2025 Jul;158(3):231-237.
  17. Furihata K, Kurabayashi A, Iwashita W, Wada N, Toi M, Yoshimichi J, Fukuhara H, Inoue K, Furihata M.
    Poorly Differentiated Carcinoma with only Clear Glandular Differentiation Arising from the Bladder Trigone: A Case of Adenocarcinoma or Urothelial Carcinoma?
    Keio J Med. 2025 Jun 25;74(2):113-118. doi: 10.2302/kjm.2024-0017-CR. Epub 2025 Mar 26.
  18. Katsumata Y, Yamamoto S, Iwata H, Kuroiwa H, Fukuhara H, Fukata S, Inoue K, Kawano T. Agent-Specific Differences in Sustained Intraoperative Hypotension during oral 5-Aminolevulinic Acid-Guided Transurethral Resection of Bladder Tumor: A Retrospective Observational Study. Photodiagnosis Photodyn Ther. Dec 18:105319. doi: 10.1016/j.pdpdt.2025.105319. 2025.
  19. Aratake T, Higashi Y, Shimizu T, Fukata S, Saito M: Extracellular Zinc Suppresses Microglial Inflammatory Shift via Zrt- and Irt-related Protein 12-Dependent Uptake.
    J. Pharmacol. Sci. 160(1): 29–36. 2026
  20. Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
    Correction to: Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial.
    Int J Clin Oncol. 2025 Jan;30(1):121-122. doi: 10.1007/s10147-024-02654-5.
  21. Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
    Effect of extending the period from oral administration of 5-aminolevulinic acid hydrochloride to photodynamic diagnosis during transurethral resection for non-muscle invasive bladder cancer on diagnostic accuracy and safety: a single-arm multicenter phase III trial.
    Int J Clin Oncol. 2025 Jan;30(1):110-120. doi: 10.1007/s10147-024-02638-5. Epub 2024 Oct 7.
  22. Fujii N, Urabe F, Yamamoto S, Inoue K, Kimura T, Shiraishi K. Extracellular vesicles in renal cell carcinoma: A review of the current landscape and future directions. Urol Oncol. Jun;43(6):370-379. doi: 10.1016/j.urolonc.2025.02.022. 2025.
  23. Kasai S, Pustimbara A, Daneshwaran G, Takahashi K, Nakajima M, Fukuhara H, Yamamoto S, Inoue K, Ogura SI. Highly malignant tumor cells accumulate less PpIX and enhanced cell dormancy increases PpIX accumulation. Photodiagnosis Photodyn Ther. Mar 8:104551. doi: 10.1016/j.pdpdt.2025.104551.2025.
  24. Katayama S, Iwata T, Nishimura S, Bekku K, Kobayashi K, Fujii N, Nishimura K, Miura N, Tohi Y, Kato T, Yamamoto S, Fukuhara H, Takamoto A, Shimizu R, Morizane S, Sasaki Y, Daizumoto K, Nagami T, Wada K, Araki M; Chu-shikoku Japan Urological Consortium. An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium. Jpn J Clin Oncol. Oct 22:hyaf163. doi: 10.1093/jjco/hyaf163. 2025.
  25. Hamada C, Shimizu T, Togo M, Higashi Y, Shimizu N, Fujimiya J, Saito M.
    Centrally administered thromboxane A2 analogue facilitates the micturition reflex in rats. Sci Rep. 2025 Nov 28;15(1):42626
  26. Taoka R, Fukuhara H, Miyake M, Kobayashi K, Ikeda A, Kanao K, Komai Y, Fujiwara R, Sato Y, Sugimoto M, Tsuzuki T, Fujimoto K, Inoue K, Oya M.
    Efficacy of photodynamic diagnosis for non-muscle invasive bladder cancer: Exploratory subject-based analysis in a prospective, single-arm, multicenter phase III trial.
    Photodiagnosis Photodyn Ther. 2025 Jun;53:104554. doi: 10.1016/j.pdpdt.2025.104554. Epub 2025 Mar 12.
  27. Tohi Y, Kobayashi K, Daizumoto K, Sekino Y, Fukuhara H, Niigawa H, Katayama S, Shimizu R, Takamoto A, Nishimura K, Nagami T, Hayashida Y, Hirama H, Shiraishi K, Tomida R, Kobatake K, Inoue K, Miyaji Y, Bekku K, Morizane S, Miura N, Wada K, Sugimoto M; Chu-shikoku Japan Urological Consortium.
    Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC.
    Jpn J Clin Oncol. 2025 Jun 5;55(6):643-649. doi: 10.1093/jjco/hyaf025.
  28. Osaki M, Yoshimatsu R, Matsumoto T, Yamanishi T, Maeda H, Osaragi K, Shibata J, Karashima T, Inoue K, Yamagami T.
    Efficacy of Automated Supply Artery Tracking Software Using Preoperative Computed Tomography for Renal Carcinoma.
    Interv Radiol (Higashimatsuyama). 2025 Mar 28;10:e20240026. doi: 10.22575/interventionalradiology.2024-0026. eCollection 2025 Mar 28.
  29. Higuchi T, Morioka S, Morisawa K, Matsukawa K, Ashida S, Suzuki T, Sakamoto S.
    Domain associated with zinc fingers-containing NF90-NF45 complex inhibits m6A modification of primary microRNA by suppressing METTL3/14 activity.
    FEBS Open Bio. 2025 Dec 6. doi: 10.1002/2211-5463.70173.

＜和文＞ 8論文

  1. 吉村理愛、清水信貴、藏野吉隆、深田聡、齊藤源顕、井上啓史
    陰圧式勃起補助具「ビガー2020」の使用により勃起機能の改善を認めた脊髄損傷患者の一例
    日本性機能学会雑誌　40(3): 2025
  2. 重久立、福原秀雄、山本新九郎、刑部博人、波越朋也、島本力、清水信貴、深田聡、蘆田真吾、辛島尚、井上啓史
    筋層非浸潤性膀胱癌に対するBCG膀胱内注入療法後の再発リスク因子の検討.
    西日泌尿, 88:11-16, 2025.
  3. 重久立、深田聡、井上啓史
    大きく変わる膀胱癌の薬物療法―筋層非浸潤性膀胱癌から転移性膀胱癌までーBCG- unresponsiveに対する新規治療法の開発状況.
    In press (癌と化学療法 53巻1号)
  4. 山本新九郎、重久立、福原秀雄、井上啓史
    【PDD-TURBTの有用性とピットフォール】偽陽性に着目したPDD-TURBTの有効性とピットフォール
    Japanese Journal of Endourology and Robotics(2436-875X) 38(1): 70-74, 2025
  5. 清水信貴、井上啓史
    排尿障害に対する内科的・外科的治療選択　前立腺手術後尿失禁に対する内科的・外科的治療選択(解説)
    西日本泌尿器科(0029-0726)87巻増刊号2 Page82-83(2025.06)
  6. 渡部媛珠、下条裕、新宮麻子、伊東秀典、福原秀雄、三宅牧人、井上啓史、藤本清秀、西村隆宏
    【生体組織光学を基盤とした光医療技術・評価の展望】上部尿路上皮癌の光線力学治療に向けた組織内光伝搬のin silico評価(原著論文)
    日本レーザー医学会誌(0288-6200)46巻2号 Page108-116(2025.07)
  7. 山本新九郎、井上啓史
    【専攻医がおさえておきたい泌尿器疾患TOP30 2025】エッセンシャルアイテム　内視鏡検査(膀胱鏡・腎盂尿管鏡)(解説)
    泌尿器外科(0914-6180)38巻特別号 Page58-67(2025.04)
  8. 清水信貴、井上啓史
    排尿障害に対する内科的・外科的治療選択　前立腺手術後尿失禁に対する内科的・外科的治療選択(解説)西日本泌尿器科(0029-0726)87巻4号 Page128-129(2025.04)

＜著書＞

  1. 吉村理愛、清水信貴
    呼吸器内科　泌尿器科：排尿障害　2025;47(2):104-112
  2. 山本新九郎、井上啓史
    06 内視鏡検査 (膀胱鏡・腎盂尿管鏡). 泌尿器外科 38 (特別): 58-67, 2025.
｜ホーム｜講座紹介｜卒前教育｜卒後研修｜診　療｜研　究｜業　績｜医局員募集｜リンク｜お問い合わせ｜